Lipid lessening drugs overview
College of Pharmacy, Al-Nahrain University, Iraq.
Review Article
GSC Biological and Pharmaceutical Sciences, 2019, 10(01), 090-095.
Article DOI: 10.30574/gscbps.2020.10.1.0004
Publication history:
Received on 07 January 2020; revised on 15 January 2020; accepted on 20 January 2020
Abstract:
Lipid lessening drugs are groups of drugs used to treat the conditions or diseases that associated with elevated blood levels of lipids (cholesterol, triglyceride) and low-density lipoprotein (LDL). These conditions known as dyslipidemias, which is hypercholesterolemia, hypertriglyceridemia, or combined hyperlipidemia. Many studies found that dyslipidemias inclined and increase the risk of other diseases such as atherosclerosis, diabetes mellitus, and coronary arteries disease.
Keywords:
Dyslipidemias; Statin; Fenofibrate; Coronary arteries disease
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
